Liver Center & Section of Digestive Diseases, Department of Internal Medicine, Yale University, New Haven, CT, USA.
Hepatology. 2013 Nov;58(5):1713-23. doi: 10.1002/hep.26554. Epub 2013 Sep 30.
Genetically determined loss of fibrocystin function causes congenital hepatic fibrosis (CHF), Caroli disease (CD), and autosomal recessive polycystic kidney disease (ARPKD). Cystic dysplasia of the intrahepatic bile ducts and progressive portal fibrosis characterize liver pathology in CHF/CD. At a cellular level, several functional morphological and signaling changes have been reported including increased levels of 3'-5'-cyclic adenosine monophosphate (cAMP). In this study we addressed the relationships between increased cAMP and β-catenin. In cholangiocytes isolated and cultured from Pkhd1(del4/del4) mice, stimulation of cAMP/PKA signaling (forskolin 10 μM) stimulated Ser(675) -phosphorylation of β-catenin, its nuclear localization, and its transcriptional activity (western blot and TOP flash assay, respectively) along with a down-regulation of E-cadherin expression (immunocytochemistry and western blot); these changes were inhibited by the PKA blocker, PKI (1 μM). The Rho-GTPase, Rac-1, was also significantly activated by cAMP in Pkhd1(del4/del4) cholangiocytes. Rac-1 inhibition blocked cAMP-dependent nuclear translocation and transcriptional activity of pSer(675) -β-catenin. Cell migration (Boyden chambers) was significantly higher in cholangiocytes obtained from Pkhd1(del4/del4) and was inhibited by: (1) PKI, (2) silencing β-catenin (siRNA), and (3) the Rac-1 inhibitor NSC 23766.
These data show that in fibrocystin-defective cholangiocytes, cAMP/PKA signaling stimulates pSer(675) -phosphorylation of β-catenin and Rac-1 activity. In the presence of activated Rac-1, pSer(675) -β-catenin is translocated to the nucleus, becomes transcriptionally active, and is responsible for increased motility of Pkhd1(del4/del4) cholangiocytes. β-Catenin-dependent changes in cell motility may be central to the pathogenesis of the disease and represent a potential therapeutic target.
纤维囊性蛋白功能的遗传缺失导致先天性肝纤维化(CHF)、Caroli 病(CD)和常染色体隐性多囊肾病(ARPKD)。CHF/CD 的肝病理学特征为肝内胆管囊性发育不良和进行性门脉纤维化。在细胞水平上,已经报道了几种功能形态和信号转导变化,包括 3'-5'-环腺苷酸(cAMP)水平升高。在这项研究中,我们研究了 cAMP 和β-连环蛋白之间的关系。在从 Pkhd1(del4/del4) 小鼠分离和培养的胆管细胞中,cAMP/PKA 信号刺激(forskolin 10 μM)刺激β-连环蛋白的 Ser(675)磷酸化、核定位及其转录活性(western blot 和 TOP flash 测定),同时下调 E-钙粘蛋白表达(免疫细胞化学和 western blot);这些变化被 PKA 阻断剂 PKI(1 μM)抑制。在 Pkhd1(del4/del4) 胆管细胞中,Rho-GTPase Rac-1 也被 cAMP 显著激活。Rac-1 抑制阻断了 cAMP 依赖性核转位和 pSer(675)-β-连环蛋白的转录活性。从 Pkhd1(del4/del4)获得的胆管细胞的细胞迁移(Boyden 室)明显更高,并受以下因素抑制:(1)PKI,(2)β-连环蛋白沉默(siRNA),和(3)Rac-1 抑制剂 NSC 23766。
这些数据表明,在纤维囊性蛋白缺陷的胆管细胞中,cAMP/PKA 信号刺激 pSer(675)-β-连环蛋白磷酸化和 Rac-1 活性。在激活的 Rac-1 存在下,pSer(675)-β-连环蛋白易位到细胞核,转录活性增加,并负责增加 Pkhd1(del4/del4)胆管细胞的迁移能力。β-连环蛋白依赖性细胞迁移变化可能是疾病发病机制的核心,代表了潜在的治疗靶点。